# Leyi Biology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/leyi-biology

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Website: www.leyibiology.com
- Latest round: Angel (Sep 6, 2023)
- Investors on record: 2

## About

Founded in 2022 and based in Hangzhou, China, Leyi Biology is a biotech company that focuses on the research and development of breath molecular diagnostic technology. In September 2023, the company raised angel+ funding from new investors Hangzhou Yuhang Jinkong Holdings and Thunderstorm VC. As of 2023, the company has 1 R&D center, 1 data center and 2 production bases, with a total production base area of 3,700 square meters. Leyi Biology has three subsidiaries, including Hunan Leya Biotechnology Co., Ltd., Hangzhou Kunyi Medical Biotechnology Co., Ltd. and Hangzhou Lewei Health Technology Co., Ltd.

The company's main product is the Bioleya exhaled gas analyzer. The Bioleya exhaled gas analyzer measures the concentrations of hydrogen, methane and carbon dioxide in human exhaled gas based on gas analysis technology of bacterial flora metabolism. The company's products are suitable for clinical diagnosis of functional gastrointestinal diseases.

## Funding rounds

- Angel, Sep 6, 2023 — Thunderstorm VC, Yuhang Jinkong Capital

## Investors

- Thunderstorm VC (https://capitalatlas.ai/funds/thunderstorm-vc) — Angel
- Yuhang Jinkong Capital (https://capitalatlas.ai/funds/yuhang-jinkong-capital) — Angel